News from Zyme and the companies we work with.
Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors
Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseases Cambridge, UK, 09 January 2026: Enhanced Genomics (‘Enhanced’ or [...]
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at [...]
Nuclera eProtein Discovery System installed at leading Universities in Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asia System strengthens Taiwan’s capabilities in protein drug discovery research Cambridge, [...]
Qureight appoints Dr Steven Bishop as Chief Medical Officer
Change in role from Chief Data Officer reflects Qureight’s continued growth and commercial success in delivering customers’ clinical studies Cambridge, UK, 07 January 2026 – Qureight, a techbio company advancing [...]
FUJIFILM Irvine Scientific Now Officially FUJIFILM Biosciences
Rebrand announced in June as part of Fujifilm Life Sciences Group restructuring becomes official FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from [...]
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media KAWASAKI, Japan and SANTA ANA, California. USA, 18 December, 2025 - Chitose Laboratory Corp., (CHITOSE), [...]
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech sectors Newcastle, UK, 15th December 2025: Atelerix, a biotech company [...]
EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal refractory epilepsy
Investment from XGEN Venture, British Business Bank, and a global biopharmaceutical company will support first-in-human Phase 1/2a clinical trials for lead candidate EPY201 targeting focal refractory epilepsy (FRE) Future financings [...]
VALANX Biotech establishes Board of Directors
Renowned industry leaders, Michael Boehler, Alexander Schwartz, Urs Spitz and Ingo Nagler, appointed to guide strategic and commercial development Vienna, Austria, 9th December 2025 – VALANX Biotech (VALANX), a biotech company [...]
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
ETD001 is well tolerated in healthy individuals at higher doses than predicted to be therapeutic for long-lasting enhancement of mucociliary clearance Results showed excellent consistency between preclinical and clinical behaviour [...]
Lab Thread Announces Beta Release of Unified Lab Software Platform
Designed to streamline collaboration across biological research, combining real-time data management, analysis, DNA sequence design, chat and review functions within one intuitive, easy to use system Interested parties invited to [...]
TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board
Experienced biotech Chair and executive will guide corporate growth and development Cambridge, UK, 2 December 2025: TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade [...]
